An update on the treatment of premature ejaculation: A systematic review
- PMID: 34552780
- PMCID: PMC8451625
- DOI: 10.1080/2090598X.2021.1943273
An update on the treatment of premature ejaculation: A systematic review
Abstract
To analyse the current therapeutic options for patients with premature ejaculation (PE) and highlight their mechanism(s) of action, effectiveness, advantages and limitations. A literature search was conducted using the PubMed database searching for articles exploring different PE treatment modalities. A Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) approach was used to report the results of the literature search. A total of 149 articles were included in this review. The currently available treatment methods for PE include behavioural therapy, local anaesthetics, tricyclic antidepressants, selective serotonin reuptake inhibitors, and selective phosphodiesterase inhibitors. Most PE treatments are either experimental or used off-label. New treatments are certainly warranted to overcome this exasperating sexual dysfunction. Abbreviations: AIPE: Arabic Index of Premature Ejaculation; CNS: central nervous system; CYP: cytochrome P450; ED: erectile dysfunction; FDA: United States Food and Drug Administration; H1: histamine receptors; 5-HT: 5-hydroxytryptamine; IELT: The intravaginal ejaculation latency time; IPE: Index of Premature Ejaculation; M1: muscarinic receptors; OCD: obsessive-compulsive disorder; PDE5: phosphodiesterase type 5; PE: premature ejaculation; PEP: Premature Ejaculation Profile; PRO: patient-reported outcome; RCT: randomised controlled trial; SS: Severance Secret (cream); SSRIs: selective serotonin reuptake inhibitors; TCAs: tricyclic antidepressants.
Keywords: Male sexual dysfunctions; premature ejaculation; selective serotonin reuptake inhibitors; treatment of premature ejaculation; tricyclic antidepressants.
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
The authors report no conflict of interest.
Figures
Similar articles
-
Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction.Eur Rev Med Pharmacol Sci. 2023 May;27(9):4248-4253. doi: 10.26355/eurrev_202305_32335. Eur Rev Med Pharmacol Sci. 2023. PMID: 37203851
-
Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review.Sex Med Rev. 2019 Jan;7(1):129-140. doi: 10.1016/j.sxmr.2018.05.001. Epub 2018 Jul 26. Sex Med Rev. 2019. PMID: 30057136
-
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Eur Urol Focus. 2017 Feb;3(1):119-129. doi: 10.1016/j.euf.2016.02.001. Epub 2016 Feb 19. Eur Urol Focus. 2017. PMID: 28720356 Free PMC article.
-
Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Urology. 2015 Oct;86(4):758-64. doi: 10.1016/j.urology.2015.06.045. Epub 2015 Aug 3. Urology. 2015. PMID: 26247816 Review.
-
Interventions to treat premature ejaculation: a systematic review short report.Health Technol Assess. 2015 Mar;19(21):1-180, v-vi. doi: 10.3310/hta19210. Health Technol Assess. 2015. PMID: 25768099 Free PMC article. Review.
Cited by
-
Dapoxetine versus glans penis injection with hyaluronic acid gel in treatment of premature ejaculation.Arab J Urol. 2023 Aug 11;22(2):75-80. doi: 10.1080/2090598X.2023.2245598. eCollection 2024. Arab J Urol. 2023. PMID: 38481413 Free PMC article.
-
The role of surgical therapy in the management of premature ejaculation: a narrative review.Transl Androl Urol. 2023 Oct 31;12(10):1589-1597. doi: 10.21037/tau-23-240. Epub 2023 Oct 24. Transl Androl Urol. 2023. PMID: 37969778 Free PMC article. Review.
-
Efficacy of Various Treatment in Premature Ejaculation: Systematic Review and Network Meta-Analysis.World J Mens Health. 2024 Apr;42(2):338-346. doi: 10.5534/wjmh.230030. Epub 2023 Aug 9. World J Mens Health. 2024. PMID: 37635338 Free PMC article.
-
Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population.BMC Urol. 2023 May 9;23(1):86. doi: 10.1186/s12894-023-01222-9. BMC Urol. 2023. PMID: 37161455 Free PMC article.
-
Progressive arousal: a new concept and definition for premature ejaculation.Sex Med. 2023 Apr 27;11(2):qfad014. doi: 10.1093/sexmed/qfad014. eCollection 2023 Apr. Sex Med. 2023. PMID: 37124144 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous